Navigation Links
Lighted Orotracheal Stylet - Non-Sterile

ProductsLighted Orotracheal Stylet - Non-Sterile
Company Aaron Medical Industries
Item Lighted Orotracheal Stylet - Non-Sterile
Features 
  • Sterile or non-sterile.
  • Orotracheal or pediatric.
  • Flexible.
  • For difficult intubations.
  • 1 per box.
  • Description Aaron manufactures two groups of flexible lighting products. The first is available both sterile and non-sterile in three different sizes 5", 10", and 15" (refers to the flexible shaft portion of the light). These lights are for use in procedures where additional light is needed.

    The second group of flexible lights is our lighted stylets, for difficult intubations.
    Info Aaron Medical Industries
    Customer Service: (800) 537-2790
    Web site: http://www.aaronmed.com

    Related medicine products :

    1. Lighted Orotracheal Stylet - Sterile
    2. Lighted Pediatric Stylet - Non-Sterile
    3. Lighted Pediatric Stylet - Sterile
    4. TAU Temporary Lead with Stylet
    5. Stylets
    6. Precut Intermediate Hi-Lo® with Stylet
    7. Satin-Slip® Intubating Stylet
    8. Cuffed Nasoral Murphy With Stylet Box
    9. Uncuffed Nasoral Murphy With Stylet
    10. Blue Line® Intubation Stylet 2.5 mm 4.5 mm
    11. Blue Line® Intubation Stylet 5.0 mm 7.0 mm
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products:
    (Date:8/1/2015)... ... , ... On Tuesday, July 28th, Symantec released a security industry whitepaper ... the attack on Anthem Inc. which resulted in one of the largest data breaches ... spear phishing campaigns. , For Joe Caruso, founder and CEO/CTO of ...
    (Date:7/31/2015)... ... July 31, 2015 , ... That’s right, the STASH ... STASH awards? The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured ... tried-and-true products that have stood the test of time. These include lighting products, ...
    (Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a ... going on in Chicago at Grant Park. The festival will end on Sunday, ... America to Chicago for the annual Lollapalooza. This unique and unbelievably popular festival ...
    (Date:7/31/2015)... ... ... Sculpted Contours Luxury Medical Aesthetics announces the arrival of the newest applicator for ... applicator in the United States as an upgrade to the CoolSmooth applicator cleared by ... required a 2 hour treatment time. The new CoolSmooth Pro reduces the treatment ...
    (Date:7/31/2015)... ... , ... M3 USA MDLinx.com, source of the Smartest Doc Board Exam Prep ... , The additions of Gastroenterology, Pulmonology and Allergy/Immunology round out an already robust selection ... exam easy and painless. MDLinx offers thousands of board-exam style questions and exam-specific ...
    Breaking Medicine News(10 mins):Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3
    ... , , , MINNEAPOLIS, ... and marketer of state-of-the-art cardiac surgery products and services, today reported financial ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ) , , Second ... or 17.0% higher than the second quarter of 2008. Revenue from ...
    ... CRANBURY, N.J., Aug. 3 Innophos Holdings, Inc. (Nasdaq: ... financial results for the second quarter 2009. , , ... Net sales for the second quarter 2009 were $166.8 million, ... the same period in 2008. Selling price increases had a positive effect ...
    ... , , SAN DIEGO, Aug. ... financial results for the second quarter ended June 30, 2009. , ... in the second quarter of 2009 of $38.0 million, or $0.48 per share, ... of 2008 of $65.8 million, or $0.89 per share, and a net loss ...
    ... , , BIRMINGHAM, Ala., Aug. 3 ... reports Operating Income of $50.4 million, or $1.52 per diluted share for ... million, or $1.62 per diluted share. For the six months ended June ... and Net Income was $82.2 million, or $2.46 per diluted share. , ...
    ... NEW YORK, Aug. 3 The uninsured issue has become a ... are currently without health insurance, a number that is continuing to ... large hospitals and clinics for sick visits and emergencies -- as ... patients arrive at hospitals and clinics, by State law, the facility ...
    ... a good time with friends, researchers say, , MONDAY, Aug. ... why one in 10 high school seniors have tried opioid ... reasons included relaxation, feeling good or getting high, experimentation and ... hydrocodone, oxycodone, hydromorphone, meperidine, morphine and codeine without a prescription, ...
    Cached Medicine News:Health News:ATS Medical Announces Second Quarter 2009 Results 2Health News:ATS Medical Announces Second Quarter 2009 Results 3Health News:ATS Medical Announces Second Quarter 2009 Results 4Health News:ATS Medical Announces Second Quarter 2009 Results 5Health News:ATS Medical Announces Second Quarter 2009 Results 6Health News:ATS Medical Announces Second Quarter 2009 Results 7Health News:ATS Medical Announces Second Quarter 2009 Results 8Health News:ATS Medical Announces Second Quarter 2009 Results 9Health News:ATS Medical Announces Second Quarter 2009 Results 10Health News:ATS Medical Announces Second Quarter 2009 Results 11Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 2Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 3Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 4Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 5Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 6Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 7Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 8Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 9Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 10Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 11Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 12Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 13Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 14Health News:Innophos Holdings, Inc. Reports Second Quarter 2009 Results 15Health News:Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 2Health News:Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 3Health News:Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 4Health News:Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 5Health News:Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 6Health News:Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 7Health News:Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 8Health News:Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 9Health News:Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 10Health News:ProAssurance Reports Second Quarter 2009 Results 2Health News:ProAssurance Reports Second Quarter 2009 Results 3
    (Date:7/30/2015)... SAN DIEGO , July 30, 2015 /PRNewswire/ ... a medical device company and manufacturer of the ... it has entered into non-exclusive Development Agreements with ... generation Tandem insulin pumps with the Dexcom G5 ... "Integrating Tandem,s next generation pump platform with ...
    (Date:7/30/2015)... 30, 2015  Amgen (NASDAQ: AMGN ) ... of 2015. Key results include: , Total ... of 2014 to $5,370 million, with 6 percent ... (etanercept), Prolia ® (denosumab), Sensipar ® ... ® (denosumab). Unfavorable changes in foreign exchange ...
    (Date:7/30/2015)... N.J. , July 30, 2015 Eisai ... in the United States , European ... FDA, EMA and MHLW, respectively) for eribulin, for the ... who have received prior chemotherapy for advanced or metastatic ... on data from a pivotal global Phase 3 clinical ...
    Breaking Medicine Technology:Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5